Better pharmacy stockroom efficiency, lower materials usage and patient convenience are benefits
The Shellpak, an award-winning compliance packaging design, has been in use for several years now, especially with a partnering program that puts generic drugs in the package for distribution at WalMart pharmacies. The design was first expanded with MWV Renew, a recyclable, tear-resistant paperboard; now it features a locking mechanism, called OptiLock, that enables the carton (which contains a blister card, usually with a 30-day, calendared allotment of pills) to be 23% smaller, while continuing the child-resistant features that enable the design to be used in compliance packaging.
An agreement is in place to package 11 types of generic drugs, manufactured by Mylan, to be assembled and delivered to WalMart pharmacies nationally from a subsidiary, International Labs (St. Petersburg, FL) that MWV acquired in 2008. (Other drugs, from other manufacturers and contract packagers, also employ Meadwestvaco compliance designs.)
“Besides the distribution efficiencies that the smaller package profile provides, patient convenience and discreetness are valued by consumers, notes Hung Le, global design VP at the Richmond, VA-based firm. “A patient doesn’t want to pull a package out of a purse or bag that says ‘Hey, look: I’m sick.’”
Dave Dwyer, a healthcare marketing VP at MWV, notes that between manufacturers’ desire for higher compliance, the CMS star ratings for healthcare providers (which makes better medication adherence a performance measure), and retail pharmacies’ desire to build relationships and loyalty with patients, all sectors of healthcare are now aligning around better adherence, and the value of compliance packaging in meeting that objective. “We’re getting involved with manufacturers now in Phase II and III of their development process, and they’re including package designs in their applications for final FDA approval,” he says.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.